UK Antitrust Watchdog Slaps $65 Million Fine On Pharma Companies In UK’s First Pay-For-Delay Case
Posted 02/16/16
A View from Constantine Cannon’s London Office
By Irene Fraile and Richard Pike
On 12 February 2016, the Competition and Markets Authority (“CMA”), UK’s competition regulator, fined a number of pharma companies for anti-competitive conduct and agreements in relation to the supply of paroxetine (an anti-depressant drug).
The anti-competitive conduct dates back to 2001, when pharmaceutical producers...